ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered ...

Technology opens the door to more accurate preclinical testing, which could enable the development of safer and more effective therapies.

In a world-first human trial, Australian researchers have achieved a major milestone in heart disease prevention with a new ...

Scientists at the University of Glasgow have successfully used the first bioengineered bone marrow model to carry out vital cancer research, offering new insights into potential therapies for the ...

Researchers say the breakthrough is an important step forward in being able to carry out medical research without the use of ...

As someone with a sound scientific background, immersed in the technical side of this work, I’ve seen firsthand how the field is now reaching a pivotal point – with two converging forces playing a key ...

Generic versions of biologic drugs could hit the market without human trials and allow the market forces to bring down costs, ...

Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) ALPHA3 ...

Scientists have discovered a groundbreaking technology that is showing remarkable success in significantly reducing bad ...